| BMPR1B |
BMPR1B: Bone morphogenetic protein receptor type IB precursor |
BMP6 |
BMP6, VGR: Bone morphogenetic protein 6 precursor |
60.460 |
Evidence |
O
|
| PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
60.200 |
Evidence |
|
| KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
NUP50 |
NUP50, NPAP60L, PRO1146: Nucleoporin 50 kDa |
60.200 |
Evidence |
|
| SNRPF |
SNRPF, PBSCF: Small nuclear ribonucleoprotein F |
WDR77 |
WDR77, HKMT1069, hCG_39991: Androgen receptor cofactor p44 |
60.200 |
Evidence |
|
| SNRPD2 |
SNRPD2, SNRPD1: Small nuclear ribonucleoprotein Sm D2 |
WDR77 |
WDR77, HKMT1069, hCG_39991: Androgen receptor cofactor p44 |
60.200 |
Evidence |
|
| TIMM23 |
TIMM23, TIM23: Mitochondrial import inner membrane translocase subunit Tim23 |
TIMM44 |
TIMM44, MIMT44, TIM44: Import inner membrane translocase subunit TIM44, mitochon |
59.840 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
POLR2F |
POLR2F, POLRF: DNA-directed RNA polymerases I, II, and III subunit RPABC2 |
59.840 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
59.640 |
Evidence |
O
|
| HCK |
IPI00029769 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
59.640 |
Evidence |
O
|
| CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
TOP2A |
TOP2A, TOP2: DNA topoisomerase 2-alpha |
59.630 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
59.630 |
Evidence |
|
| TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
58.660 |
Evidence |
O
|
| ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
CFL2 |
CFL2: Cofilin-2 |
58.230 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
57.750 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
57.750 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
57.700 |
Evidence |
|
| IPO7 |
IPO7: Uncharacterized protein IPO7 |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
57.700 |
Evidence |
O
|
| VAMP1 |
VAMP1, SYB1: Vesicle-associated membrane protein 1 |
STX1A |
STX1A, STX1: Syntaxin-1A |
57.420 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
57.130 |
Evidence |
O
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
56.780 |
Evidence |
O
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
56.780 |
Evidence |
|
| POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2L |
POLR2L: DNA-directed RNA polymerases I, II, and III subunit RPABC5 |
56.670 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
56.220 |
Evidence |
|
| GRB10 |
IPI00012752 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
56.200 |
Evidence |
|
| BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
BMF |
BMF: Bcl-2-modifying factor |
56.200 |
Evidence |
|
-